Population-based perspective of anti-neuronal autoantibodies in patients with idiopathic late onset cerebellar ataxia (ILOCA)

Population-based perspective of anti-neuronal autoantibodies in patients with idiopathic late onset cerebellar ataxia (ILOCA)

Detalhes bibliográficos
Principais autores:	Muzaimi, M, Clover, L, Lang, B, Vincent, A, Wiles, M, Robertson, N
Formato:	Conference item
Publicado em:	2004

Registros relacionados

Role of antineuronal autoantibodies in population based samples of apparently idiopathic late onset cerebellar ataxia (ILOCA)
por: Muzaimi, M, et al.
Publicado em: (2003)

The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
por: Muzaimi, M, et al.
Publicado em: (2004)

Autoantibody screening in subacute cerebellar ataxia.
por: Trivedi, R, et al.
Publicado em: (2000)

Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies
por: Lim, S., et al.
Publicado em: (2009)

Robotic compensation of cerebellar ataxia
por: Smith, Eric D., S.M. Massachusetts Institute of Technology
Publicado em: (2008)

The future of diagnostics in Cerebellar Ataxias
por: Nemeth, A
Publicado em: (2010)

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
por: Honnorat, J, et al.
Publicado em: (2001)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
por: Becker, E, et al.
Publicado em: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
por: Becker, E, et al.
Publicado em: (2012)

Associative learning in patients with cerebellar ataxia.
por: Tucker, J, et al.
Publicado em: (1996)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
por: Lorenzoni, P, et al.
Publicado em: (2008)

Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
por: Mirabelli-Badenier, M, et al.
Publicado em: (2012)

Autoantibodies and the nervous system
por: Vincent, A, et al.
Publicado em: (2008)

Do mutations in the murine ataxia gene TRPC3 cause cerebellar ataxia in humans?
por: Fogel, B, et al.
Publicado em: (2015)

Candidate screening of the TRPC3 gene in cerebellar ataxia.
por: Becker, E, et al.
Publicado em: (2011)

From Mice to Men: TRPC3 in Cerebellar Ataxia.
por: Becker, E
Publicado em: (2015)

Candidate screening of the TRPC3 gene in cerebellar ataxia.
por: Becker, E, et al.
Publicado em: (2011)

Genes for autosomal recessive cerebellar ataxia: order from chaos?
por: Nemeth, A, et al.
Publicado em: (2001)

Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.
por: Suleiman, J, et al.
Publicado em: (2013)

Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
por: Watson, L, et al.
Publicado em: (2015)

Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34.
por: Németh, A, et al.
Publicado em: (2000)

Idiopathic pulmonary fibrosis: a paradigm of late-onset, single-gene human disease?
por: Chapman, S, et al.
Publicado em: (2014)

Co-occurrence of acute ophthalmoplegia (without ataxia) and idiopathic intracranial hypertension
por: Yeak, Justin, et al.
Publicado em: (2019)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, R, et al.
Publicado em: (2020)

The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.
por: Vincent, A, et al.
Publicado em: (2010)

The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia.
por: Becker, E
Publicado em: (2014)

Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells
por: Wong, M, et al.
Publicado em: (2017)

Autoantibodies in epilepsy
por: Lang, B, et al.
Publicado em: (2007)

Pathogenic autoantibodies to neuronal proteins in neurological disorders.
por: Vincent, A, et al.
Publicado em: (1999)

Autoantibodies in patients with gut motility disorders and enteric neuropathy.
por: Törnblom, H, et al.
Publicado em: (2007)

Idiopathic aneurysms of distal cerebellar arteries: endovascular treatment after rupture.
por: Mitsos, A, et al.
Publicado em: (2008)

MAPPING THE GENE FOR ACETAZOLAMIDE-RESPONSIVE HEREDITARY PAROXYSMAL CEREBELLAR-ATAXIA TO CHROMOSOME-19P
por: Bulman, D, et al.
Publicado em: (1995)

Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p.
por: von Brederlow, B, et al.
Publicado em: (1995)

A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse.
por: Isaacs, A, et al.
Publicado em: (2003)

A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse
por: Isaacs, A, et al.
Publicado em: (2003)

Understanding the disease mechanisms of cerebellar ataxia through induced pluripotent stem cell models
por: Wong, M
Publicado em: (2018)

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes.
por: Ekizoglu, E, et al.
Publicado em: (2014)

Do neuronal autoantibodies cause psychosis? a neuroimmunological perspective
por: Coutinho, E, et al.
Publicado em: (2014)

Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective.
por: Coutinho, E, et al.
Publicado em: (2014)

An apparently non-maternally inherited syndrome of seizures, ataxia and ophthalmoplegia, with distinctive cerebellar lesions, in an Irish pedigree
por: Menon, R, et al.
Publicado em: (2005)